Related Experiment Video
Updated: Jul 17, 2026

12:09
Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
Published on: August 10, 2022
Label-free candidate dOCM biomarkers associated with blastocyst quality using total cell count as a proxy
Yunqin Zhao1, Saanjali Majmundar1,2, Jacob Stoebner1
1Vanderbilt University, Vanderbilt Biophotonics Center, Department of Biomedical Engineering, Nashville, TN 37232, USA.
Biomedical Optics Express
|July 16, 2026
Summary
Dynamic optical coherence microscopy (dOCM) offers new quantitative biomarkers for embryo quality. Band-resolved metrics reveal distinct intracellular fluctuation spectra correlating with blastocyst cell count, improving upon subjective grading.
Area of Science:
- Biomedical Engineering
- Reproductive Biology
- Microscopy
Background:
- Current blastocyst grading in in vitro fertilization (IVF) relies on subjective morphological assessment.
- There is a need for quantitative, label-free biomarkers to objectively assess blastocyst quality.
Purpose of the Study:
- To investigate the potential of dynamic optical coherence microscopy (dOCM) for quantitative assessment of intracellular fluctuations in murine blastocysts.
- To identify novel label-free biomarkers for blastocyst quality using dOCM.
Main Methods:
- Application of dynamic optical coherence microscopy (dOCM) to murine blastocysts.
- Quantification of intracellular fluctuation spectra using full- and band-resolved metrics (mean frequency, RMS bandwidth, motility amplitude, variance fraction).
- Comparison of dOCM metrics between low- and high-cell-count blastocyst cohorts using cell counting as a benchmark.
Main Results:
- Full-band dOCM metrics did not show significant differences between low- and high-cell-count blastocysts.
- Band-resolved analysis revealed higher mid-band mean frequency and increased mid-band RMS bandwidth in higher-cell-count embryos.
- A significant decrease in low-frequency variance fraction was observed in higher-cell-count embryos.
Conclusions:
- Frequency-specific dOCM signatures show promise as candidate biomarkers for objective blastocyst quality assessment.
- Band-resolved analysis of intracellular dynamics provides more discriminatory information than full-band analysis.
- dOCM offers a label-free, quantitative approach to potentially improve IVF outcomes.
